Literature DB >> 22264980

Feasibility and construct validity of PROMIS and "legacy" instruments in an academic scleroderma clinic.

Dinesh Khanna1, Paul Maranian, Nan Rothrock, David Cella, Richard Gershon, Puja P Khanna, Brennan Spiegel, Daniel E Furst, Phil J Clements, Amber Bechtel, Ron D Hays.   

Abstract

OBJECTIVE: The National Institutes of Health Patient-Reported Outcomes Measurement Information System (PROMIS) roadmap initiative is a cooperative group program of research designed to develop, evaluate, and standardize item banks to measure patient-reported outcomes relevant across medical conditions. The objective of the current study was to assess feasibility and evaluation of the construct validity of PROMIS item banks versus legacy measures in an observational study in systemic sclerosis (SSc). We hypothesized that the PROMIS item banks can be administered in a clinical setting if there is adequate staff support without disrupting the flow of clinic.
METHODS: Patients with SSc in a single academic center completed computerized adaptive test (CAT) administered PROMIS item banks during the clinic visit and legacy measures (using paper and pencil). The construct validity of PROMIS items was evaluated by examining correlations with corresponding legacy measures using multitrait-multimethod analysis.
RESULTS: Participants consisted of 143 SSc patients with an average age of 51.5 years; 71% were female and 68% were white. The average number of items completed for each CAT-administered item bank ranged from 5 to 8 (69 CAT items per patient), and the average time to complete each CAT-administered item bank ranged from 48 seconds to 1.9 minutes per patient (average time = 11.9 minutes/per patient for 11 banks). All correlations between PROMIS domains and respective legacy measures were large and in the hypothesized direction (ranged from 0.61 to 0.82).
CONCLUSION: Our study supports the construct validity of the CAT-administered PROMIS item banks and shows that they can be administered successfully in a clinic with support staff. Future studies should assess the feasibility of PROMIS item banks in a busy clinical practice.
Copyright © 2012 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22264980      PMCID: PMC3457915          DOI: 10.1016/j.jval.2011.08.006

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  24 in total

1.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

2.  Body image dissatisfaction among women with scleroderma: extent and relationship to psychosocial function.

Authors:  Lisa M Benrud-Larson; Leslie J Heinberg; Christy Boling; Jeffrey Reed; Barbara White; Fredrick M Wigley; Jennifer A Haythornthwaite
Journal:  Health Psychol       Date:  2003-03       Impact factor: 4.267

3.  Representativeness of the Patient-Reported Outcomes Measurement Information System Internet panel.

Authors:  Honghu Liu; David Cella; Richard Gershon; Jie Shen; Leo S Morales; William Riley; Ron D Hays
Journal:  J Clin Epidemiol       Date:  2010-08-05       Impact factor: 6.437

Review 4.  Systemic sclerosis (scleroderma) and related disorders: clinical aspects.

Authors:  P J Clements
Journal:  Baillieres Best Pract Res Clin Rheumatol       Date:  2000-03       Impact factor: 4.098

5.  Comparison of responses to SF-36 Health Survey questions with one-week and four-week recall periods.

Authors:  S D Keller; M S Bayliss; J E Ware; M A Hsu; A M Damiano; T F Goss
Journal:  Health Serv Res       Date:  1997-08       Impact factor: 3.402

6.  Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale).

Authors:  E M Andresen; J A Malmgren; W B Carter; D L Patrick
Journal:  Am J Prev Med       Date:  1994 Mar-Apr       Impact factor: 5.043

7.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

Review 8.  Psychologic factors in scleroderma.

Authors:  Jennifer A Haythornthwaite; Leslie J Heinberg; Lynanne McGuire
Journal:  Rheum Dis Clin North Am       Date:  2003-05       Impact factor: 2.670

9.  Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population.

Authors:  Maureen D Mayes; James V Lacey; Jennifer Beebe-Dimmer; Brenda W Gillespie; Brenda Cooper; Timothy J Laing; David Schottenfeld
Journal:  Arthritis Rheum       Date:  2003-08

10.  Measurement of patient outcome in arthritis.

Authors:  J F Fries; P Spitz; R G Kraines; H R Holman
Journal:  Arthritis Rheum       Date:  1980-02
View more
  28 in total

1.  Longitudinal evaluation of PROMIS-29 and FACIT-dyspnea short forms in systemic sclerosis.

Authors:  Monique E Hinchcliff; Jennifer L Beaumont; Mary A Carns; Sofia Podlusky; Krishna Thavarajah; John Varga; David Cella; Rowland W Chang
Journal:  J Rheumatol       Date:  2014-11-01       Impact factor: 4.666

2.  Reducing survey burden: feasibility and validity of PROMIS measures in multiple sclerosis.

Authors:  Angela Senders; Douglas Hanes; Dennis Bourdette; Ruth Whitham; Lynne Shinto
Journal:  Mult Scler       Date:  2014-01-08       Impact factor: 6.312

3.  Validation of the Computerized Adaptive Test for Mental Health in Primary Care.

Authors:  Andrea K Graham; Alexa Minc; Erin Staab; David G Beiser; Robert D Gibbons; Neda Laiteerapong
Journal:  Ann Fam Med       Date:  2019-01       Impact factor: 5.166

4.  Health State Utilities and Disease Duration in Systemic Sclerosis: Is There an Association?

Authors:  Adam J N Raymakers; Nicole W Tsao; Carlo A Marra; Philip J Clements; Dinesh Khanna
Journal:  J Rheumatol       Date:  2016-08-01       Impact factor: 4.666

Review 5.  Patient reported outcomes in rheumatoid arthritis clinical trials.

Authors:  Ana-Maria Orbai; Clifton O Bingham
Journal:  Curr Rheumatol Rep       Date:  2015-04       Impact factor: 4.592

6.  An examination of the PROMIS(®) pediatric instruments to assess mobility in children with cerebral palsy.

Authors:  Anna L Kratz; Mary D Slavin; M J Mulcahey; Alan M Jette; David S Tulsky; Stephen M Haley
Journal:  Qual Life Res       Date:  2013-03-31       Impact factor: 4.147

7.  Performance of the Patient-Reported Outcomes Measurement Information System-29 in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort Study.

Authors:  Linda Kwakkenbos; Brett D Thombs; Dinesh Khanna; Marie-Eve Carrier; Murray Baron; Daniel E Furst; Karen Gottesman; Frank van den Hoogen; Vanessa L Malcarne; Maureen D Mayes; Luc Mouthon; Warren R Nielson; Serge Poiraudeau; Robert Riggs; Maureen Sauvé; Fredrick Wigley; Marie Hudson; Susan J Bartlett
Journal:  Rheumatology (Oxford)       Date:  2017-08-01       Impact factor: 7.580

8.  Validation of PROMIS emotional distress short form scales for cervical cancer.

Authors:  Justin Wilford; Kathryn Osann; Susie Hsieh; Bradley Monk; Edward Nelson; Lari Wenzel
Journal:  Gynecol Oncol       Date:  2018-08-02       Impact factor: 5.482

9.  Measuring pain phenomena after spinal cord injury: Development and psychometric properties of the SCI-QOL Pain Interference and Pain Behavior assessment tools.

Authors:  Matthew L Cohen; Pamela A Kisala; Trevor A Dyson-Hudson; David S Tulsky
Journal:  J Spinal Cord Med       Date:  2017-02-10       Impact factor: 1.985

Review 10.  Patient-Reported Outcomes in Systemic Lupus Erythematosus.

Authors:  Mary Mahieu; Susan Yount; Rosalind Ramsey-Goldman
Journal:  Rheum Dis Clin North Am       Date:  2016-03-17       Impact factor: 2.670

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.